title: Clinical update on Humalog Mix25 a novel pre-mixed formulation of insulin lispro and NPL.
authors.affiliation: Eli Lilly and Company, Indianapolis, USA.
authors.forename: M
authors.initials: M
authors.lastname: Herz
mesh_terms: D001786:Blood Glucose / Q000032:analysis; D018592:Cross-Over Studies; D003924:Diabetes Mellitus, Type 2 / Q000097:blood / Q000188:drug therapy*; D006801:Humans; D007004:Hypoglycemic Agents / Q000008:administration & dosage* / Q000493:pharmacokinetics; D007267:Injections; D007328:Insulin / Q000008:administration & dosage* / Q000031:analogs & derivatives* / Q000493:pharmacokinetics; D061268:Insulin Lispro; D019518:Postprandial Period; D016032:Randomized Controlled Trials as Topic
chemical_list: D001786:Blood Glucose; D007004:Hypoglycemic Agents; D007328:Insulin; D061268:Insulin Lispro